Skip to main content

Erin Burkhart

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Erin Burkhart

Earlier roles on record: Chief Accounting Officer at Biomarin Pharmaceutical Inc (BMRN) until September 2, 2025. Biomarin Pharmaceutical Inc reported in an 8-K filed August 11, 2025 that Erin Burkhart resigned as Group Vice President, Chief Accounting Officer and principal accounting officer, effective September 2, 2025.

“On August 5, 2025, Erin Burkhart, the Group Vice President, Chief Accounting Officer and principal accounting officer of BioMarin Pharmaceutical Inc. (the Company) notified the Company of her decision to resign, effective as of September 2, 2025 (the Effective Date).”
Biomarin Pharmaceutical Inc Form 8-K, filed August 11, 2025 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.